Psoriasis therapy (Apollo Life Sciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePsoriasis therapy (Apollo Life Sciences)
Drug Alias NameALS-00T2-0501
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Life Sciences
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A